Fertility preservation in patients with gynecological cancer - is it possible?

The aim of this review article is to present current options for fertility preservation in young women with gynecological tumors (ovarian, endometrial or cervical cancer). An early pretreatment referral multidisciplinary team which consists general gynecologists, gynecologic oncologists, embryologists, radiologists, pathologists, and reproductive endocrinologists should be suggested cancer, concerning the risks benefits options. Only a small percentage patients ovarian cancer borderline tumors, are appropriate candidates (FIGO stage IA IC epithelial Following oophorectomy, tissue oocytes removed from ovary use cryopreservation; after completion oncological treatment patient undergoes orthotopic retransplantation whereas may used vitro fertilization. Live birth rates up 53.8% have been reported selected patients. In means conserving uterus. Appropriate younger well differentiated does not invade myometrium. Fertility hormonal, based on progestins. After treatment, frequent follow-ups necessary, sampling (via curettage biopsy) remaining standard approach follow- up. progestin therapy around 60%, even higher help assisted procedures. can considered early-stage disease IA1, IA2, IB1). Cone biopsy conization followed by laparoscopic lymphadenectomy has described as an procedure, conception 47%.